← Back
product
Humira
Last discussed Sep 28, 2026
A biologic drug (adalimumab) by AbbVie used for rheumatoid arthritis and other inflammatory conditions, known for its extensive patent portfolio strategy.
Recently discussed in
409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles
Lloyd B. Klickstein · Sep 28, 2026
What creators say
LB
Lloyd B. Klickstein
mentioned
"One good example would be AbbVie and Humira. They patented every single little thing around that drug that they could. It was a huge winner for them and they wanted to keep it protected as long as they possibly could."
More from Lloyd B. Klickstein →Keep exploring
About this data
- ✓44,000+ mentions extracted from real podcast transcripts
- ✓Every quote links to the source episode
- ✓Sponsored mentions are always labeled
- ✓Critical takes are shown, never filtered out
Get an email when a new creator recommends it